Naxillin

CAS No. 301176-96-5

Naxillin( —— )

Catalog No. M34108 CAS No. 301176-96-5

Naxillin is a non-growth hormone-like molecule that induces lateral root development by positively affecting the IBA to IAA transition at specific sites in the root.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 686 In Stock
10MG 938 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Naxillin
  • Note
    Research use only, not for human use.
  • Brief Description
    Naxillin is a non-growth hormone-like molecule that induces lateral root development by positively affecting the IBA to IAA transition at specific sites in the root.
  • Description
    Naxillin is a non-growth hormone-like molecule that induces lateral root development by positively affecting the IBA to IAA transition at specific sites in the root.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    301176-96-5
  • Formula Weight
    313.3
  • Molecular Formula
    C13H10F3N3OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    FC(F)(F)C1=CC=CC(=C1)C=2OC(C=NNC(=S)N)=CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • NH2-KLGADTDGEQDQHMTY...

    NH2-QGGYTMHQDQEGDTDAGLK-COOH is a synthetic peptide chain with an amine group attached to lysine and an carboxyl group attached to glutamine.

  • Isosakuranin

    Isosakuranin is a product from Paliurus ramosissimus.

  • Euchrestaflavanone B

    Euchrestaflavanone B shows antibacterial activity against Gram positive bacteria, Staphylococcus aureus, Bacillus subtilis and Bacillus cereus. Euchrestaflavanone B may function by inhibiting oncogenic disease, at least in part, through the inhibition of protein kinase CKII activity.